Featured Trends
We’ve sliced and diced our portfolio into distinct “trends” that define our edge.
Climate 100
We are pleased to report that as of April 2021 the SOSV Climate Tech 100 have raised $1.85 billion from investors and have a market cap of $5.65 billion. The average company is four years old. SOSV (our parent fund) has invested $89 million in these companies and was in most cases the first investor, though we continued investing through early rounds.
IndieBio has never been one to shy away from the riskiest and most impactful investments for our planet. In fact, we embrace them.
Female Founder
Boosting female representation in the startup world is an ongoing challenge, but we’re dedicated to gender balance, not only because it’s the right thing to do, but because we would be dismissing impressive companies otherwise. We’ve found that more gender balance leads to better workplace culture and better ideas being exchanged.
Future of Food
It’s not just that we can make meat and fish in the lab, or with mushrooms and chickpeas. It’s not just that AI can predict the best plant ingredients to make the best tasting milk and yogurt. And it’s not just that yeast can be fermented to produce the healthier and better food preservatives. We’re diving deep every day into the foods that will satisfy novelty-seekers and conventionalists alike.
We’re putting big bets on the newest technologies and trends we think are ahead of the curve.
Future of Medicine
Medicine ain’t what it used to be. Today, bloodletting, skull-drilling and giving children cocaine for toothaches are relics of the past. Tomorrow, so too will addictive opioids, chemotherapy, and psychiatric drugs that are non-selectively bathing our bodies in chemicals.
The future of medicine is an exciting one, and we’re excited to share the most exciting technologies that enable the next wave of medicine and healthcare.
Impact
Our mission has always been Human and Planetary Health from the beginning, so it’s hard to say which of our companies are “impact” companies (in some ways, they all are).
Here, we narrowed down the startups that are directly addressing sustainability issues, improving public health, mitigating inequality, and democratizing access to infrastructure and technologies.
New Frontiers
Raising Now
Every season of the year, a new batch and about one-sixth of our alumni are in raise mode. These companies are currently raising and would love to talk to interested investors. We can set up those meetings or you can contact the companies directly.
Sustainable Solutions
Why we invested: At a small networking event, the founders said softly to us: “we are working on a technology that can completely upend the entire sequencing industry.” We leaned in to listen; after all, the founders have been working the front lines during every major pivotal point in sequencing history: Illumina’s acquisition of Solexa […]
Why we invested: In the $220B copper mining industry, “heap leaching” of waste rock with low concentrations of ore has become a standard practice. Heap leaching works in two ways: 1) sulfuric acid is sprayed on top to trickle through the heaps, and 2) natural microbes in the heaps also help dissolve the copper mineral into […]
Why we invested: The biggest risk in cancer immunotherapy is the safety: the cancer targets (i.e., neoantigens) are not differentiated enough from healthy cells, and can therefore lead to the immune system attacking the patient’s. When we met Dr. Corey Dambacher (the founder of Rybodyn), he said he has been sitting on a treasure trove […]
Why we invested: The world’s biggest meat, produce, and animal health companies take vast sums of money and light it on fire on a recurring basis. They don’t want to do this, but due to consistent shortcoming in pathogen detection no one has managed to avoid the steady recurrence of recall and herd losses. It […]
Why we invested: For us to invest in alt proteins in 2024 requires that we see a team and product that are laser focused on solving a deeply felt commercial problem at previously unheard of speed. Since our first meeting, the NXW founders–themselves food industry veterans–have shown their ability to move fast while building trust […]
Why we invested: The message from the market is crystal clear: electric vehicles need to be cheaper. Since up to 40% of an electric vehicle is the battery, and in turn 70% of the cost of the battery is in materials, it’s an imperative for the industry to develop cheaper and higher performing materials. Silicon […]
Why we invested: For all the hype of cell therapies, to get beyond the 5% of eligible patients who receive such therapies today, the market needs 1) higher transfection success, and 2) multi-protein delivery in one construct. The founder of Able sciences are veteran drug developers who invented a self-amplifying RNA that delivers on both […]
Why we invested: Our investment in BryoSphere is an addition to SOSV’s next-gen biomanufacturing portfolio that spans a diversity of chassis, processes, vessels, and feedstocks. BryoSphere is one of the only companies in the world to use moss cells in photobioreactors as an expression system. These ancient plants are really good at making compounds to […]
Farm Minerals has the cheapest method of making emissions-free fertilizers in the world. How cheap? Cheaper than Haber-Bosch. That’s not in the future, or when scaled up, or after $500M of capex is put in the ground. That’s today. At our current production facility, we can make $10M of fertilizers per month. Our nutrients come […]
California Organic makes the world’s first green ammonia that is California-certified organic. Already in market and growing rapidly, our organic ammonia is made from farm & ag wastes via a bulk fermentation bioprocess. Until today, all organic agriculture has used nitrate fertilizers, which have several inefficiencies. Nitrates are in slurries and so can’t go into […]